NCT07065383View on ClinicalTrials.gov

Rebalancing the Fat Content of the Heart and Muscles

NANot yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

July 31, 2028

Study Completion Date

July 31, 2028

Conditions
Diabetes Mellitus Type 2
Interventions
DRUG

Semaglutide administration plus dietary counselling and physical activity encouragement

Semaglutide administration plus dietary counselling and physical activity encouragement

DRUG

Semaglutide plus a personalised and supervised program of resistance and endurance training

Semaglutide administration plus a personalised and supervised program of resistance and endurance training.

All Listed Sponsors
collaborator

NHS Grampian

OTHER_GOV

lead

University of Aberdeen

OTHER

NCT07065383 - Rebalancing the Fat Content of the Heart and Muscles | Biotech Hunter | Biotech Hunter